---
title: "Lifeward Ltd. (LFWD.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/LFWD.US.md"
symbol: "LFWD.US"
name: "Lifeward Ltd."
industry: "醫療器械"
---

# Lifeward Ltd. (LFWD.US)

| Item | Detail |
|------|--------|
| Industry | 醫療器械 |
| Location | 美股市場 |
| Website | [golifeward.com](https://golifeward.com) |

## Company Profile

Lifeward Ltd.是一家醫療設備公司，設計、開發並商業化技術，以促進美國、歐洲、亞太地區及國際上身體和神經系統疾病患者在康复和日常生活中的移動性和健康。它提供 ReWalk 個人外骨骼和康复外骨骼設備；ReStore，一種軟外骨骼套裝，旨在用于因中風導致下肢殘疾的個體康复；AlterG 抗重力系統，用于身體和神經康复及運動訓練；MyoCycle 設備；以及 ReBoot，一種個人軟外骨骼套裝，供中風后個體在家和社區使用。該公司直接向機構和個人市場銷售其產品，也通過第三方分銷商進行銷售。該公司曾被稱為 ReWalk Robotics Ltd

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-25T04:30:15.000Z

**Overall: C (0.60)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 102 / 185 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -2.02% |  |
| Net Profit YoY | -54.61% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.60 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 91.65M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 24.50M |  |


**Multi Score**: C

#### Profit Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -127.95% | E |
| Profit Margin | -121.82% | E |
| Gross Margin | 43.70% | B |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -2.02% | D |
| Net Profit YoY | -54.61% | D |
| Total Assets YoY | -49.38% | E |
| Net Assets YoY | -62.37% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -82.09% | D |
| OCF YoY | -2.02% | D |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.71 | B |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 44.95% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Lifeward Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "-127.95%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-121.82%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "43.70%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-2.02%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-54.61%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-49.38%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-62.37%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-82.09%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-2.02%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.71",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "44.95%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 啟迪醫療 (US.INSP) | A | B | A | A | B | A |
| 02 | Delcath (US.DCTH) | C | A | A | A | A | A |
| 03 | 雅培 (US.ABT) | B | C | C | B | C | B |
| 04 | 直覺外科 (US.ISRG) | A | B | C | A | B | B |
| 05 | 史賽克 (US.SYK) | A | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.26 | 64/181 | - | - | - |
| PB | 0.60 | 15/181 | 0.89 | 0.74 | 0.60 |
| PS (TTM) | 0.31 | 11/181 | 0.57 | 0.48 | 0.40 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-17T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 50% |
| Overweight | 1 | 50% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 5.78 |
| Highest Target | 120.00 |
| Lowest Target | 54.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/LFWD.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/LFWD.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/LFWD.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.